...
首页> 外文期刊>The Journal of trauma >Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP.
【24h】

Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP.

机译:慢性肝病评分系统是否可以预测创伤性肝病患者的预后? MELD和CTP的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Although the Child-Turcotte-Pugh (CTP) score is an established outcome prediction tool for patients with liver disease, the Model for End-Stage Liver Disease (MELD) score has recently supplanted CTP for patients awaiting transplantation. Currently, data regarding the use of CTP in trauma is limited, whereas MELD remains unstudied. We compared MELD and CTP to determine which scoring system is a better clinical outcome predictor after trauma. METHODS: A review of trauma admissions during 2003-2008 revealed 68 patients with chronic liver disease. Single and multiple variable analyses determined predictors of hepatic complications and survival. MELD and CTP were compared using odds ratios and area under the receiver operating curve (AUC) analyses. A p value 0.05), although both CTP score and class were predictive (p < 0.05; AUC > 0.70). CONCLUSION: Trauma patients suffering from cirrhosis can be expected to have poorer than predicted outcomes using traditional trauma scoring systems, regardless of injury severity. Scoring systems for chronic liver disease offer a more effective alternative. We compared two scoring systems, MELD and CTP, and determined that CTP was the better predictor of hepatic complications and survival in our study population.
机译:背景:尽管Child-Turcotte-Pugh(CTP)评分是针对肝病患者的既定结果预测工具,但终末期肝病模型(MELD)评分最近已取代了等待移植患者的CTP。目前,有关在创伤中使用CTP的数据是有限的,而MELD仍未研究。我们比较了MELD和CTP,以确定哪个评分系统是创伤后更好的临床预后指标。方法:回顾2003-2008年期间收治的创伤患者,共发现68例慢性肝病患者。单变量和多变量分析确定了肝并发症和生存的预测因素。使用比值比和接收器工作曲线(AUC)分析下的面积比较了MELD和CTP。 p值 0.70),但赔率和AUC确定MELD不能预测肝并发症或医院生存(p> 0.05)。结论:不管损伤的严重程度如何,使用传统的创伤评分系统可以预期创伤性肝硬化患者的预后较预期差。慢性肝病评分系统提供了更有效的选择。我们比较了两种评分系统MELD和CTP,并确定CTP是我们研究人群中肝并发症和生存率的更好预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号